NCT00921856View on ClinicalTrials.gov

Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD)

NARecruitingINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Coronary VasospasmMicrovascular AnginaCoronary Artery Disease

Interventions

OTHER

Intracoronary acetylcholine provocation test

Intracoronary provocation of coronary spasm with acetylcholine in augmented dosages of 2 µg, 20 µg, 100 µg and 200 µg non-selectively in the LCA as well as 80 µg in the RCA. During the procedure, a 12 channel ECG will be recorded.

Trial Locations (1)

70376

RECRUITING

Robert Bosch Medical Center, Stuttgart

All Listed Sponsors

collaborator

Deutsche Stiftung für Herzforschung

OTHER

lead

Peter Ong, MD

OTHER

NCT00921856 - Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD) | Biotech Hunter | Biotech Hunter